Key players in these pathways include EGFR, PI3K, Akt, mTOR, and PTEN [11], which are commonly mutated in lung cancer, and are found to be upregulated by morphine via MOR in non-small-cell lung cancer [7,14]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.